Form 4 holding
Director
TENAX THERAPEUTICS, INC.
- Security class
- Pre-Funded Common Stock Purchase Warrants
- Shares / value
- 10,596,027
- Estimated value
- Report date
- 18 May 2022
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount